PROCTER & GAMBLE HEALTH | SMS PHARMA | PROCTER & GAMBLE HEALTH/ SMS PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 42.7 | 81.0% | View Chart |
P/BV | x | 10.6 | 3.8 | 276.2% | View Chart |
Dividend Yield | % | 2.0 | 0.1 | 1,393.2% |
PROCTER & GAMBLE HEALTH SMS PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SMS PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ SMS PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 110 | 4,873.4% | |
Low | Rs | 3,883 | 55 | 7,124.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 58.1 | 1,276.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0.5 | 30,127.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 4.3 | 3,647.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.30 | 31,666.7% | |
Avg Dividend yield | % | 2.1 | 0.4 | 563.6% | |
Book value per share (Unadj.) | Rs | 447.6 | 54.4 | 822.8% | |
Shares outstanding (eoy) | m | 16.60 | 84.65 | 19.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.4 | 440.3% | |
Avg P/E ratio | x | 33.5 | 179.4 | 18.6% | |
P/CF ratio (eoy) | x | 29.8 | 19.3 | 154.0% | |
Price / Book Value ratio | x | 10.3 | 1.5 | 682.9% | |
Dividend payout | % | 68.7 | 65.4 | 105.1% | |
Avg Mkt Cap | Rs m | 76,761 | 6,967 | 1,101.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 550 | 374.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 4,914 | 250.2% | |
Other income | Rs m | 184 | 49 | 376.4% | |
Total revenues | Rs m | 12,480 | 4,963 | 251.5% | |
Gross profit | Rs m | 3,247 | 546 | 595.0% | |
Depreciation | Rs m | 281 | 321 | 87.5% | |
Interest | Rs m | 8 | 220 | 3.5% | |
Profit before tax | Rs m | 3,142 | 53 | 5,874.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 15 | 5,783.6% | |
Profit after tax | Rs m | 2,295 | 39 | 5,908.1% | |
Gross profit margin | % | 26.4 | 11.1 | 237.8% | |
Effective tax rate | % | 27.0 | 27.4 | 98.5% | |
Net profit margin | % | 18.7 | 0.8 | 2,361.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 4,107 | 285.2% | |
Current liabilities | Rs m | 6,791 | 2,550 | 266.3% | |
Net working cap to sales | % | 40.0 | 31.7 | 126.3% | |
Current ratio | x | 1.7 | 1.6 | 107.1% | |
Inventory Days | Days | 263 | 18 | 1,489.4% | |
Debtors Days | Days | 343 | 1,102 | 31.2% | |
Net fixed assets | Rs m | 10,617 | 4,690 | 226.4% | |
Share capital | Rs m | 166 | 85 | 196.1% | |
"Free" reserves | Rs m | 7,265 | 4,521 | 160.7% | |
Net worth | Rs m | 7,431 | 4,605 | 161.3% | |
Long term debt | Rs m | 0 | 1,211 | 0.0% | |
Total assets | Rs m | 22,330 | 8,797 | 253.8% | |
Interest coverage | x | 409.1 | 1.2 | 32,897.8% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 98.6% | |
Return on assets | % | 10.3 | 2.9 | 350.7% | |
Return on equity | % | 30.9 | 0.8 | 3,661.6% | |
Return on capital | % | 42.4 | 4.7 | 902.3% | |
Exports to sales | % | 0 | 64.4 | 0.0% | |
Imports to sales | % | 13.1 | 25.7 | 50.9% | |
Exports (fob) | Rs m | NA | 3,165 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,261 | 127.3% | |
Fx inflow | Rs m | 1,465 | 3,165 | 46.3% | |
Fx outflow | Rs m | 1,605 | 1,270 | 126.4% | |
Net fx | Rs m | -140 | 1,895 | -7.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 225 | 1,051.2% | |
From Investments | Rs m | -215 | -297 | 72.4% | |
From Financial Activity | Rs m | -985 | -320 | 308.0% | |
Net Cashflow | Rs m | 1,160 | -392 | -296.0% |
Indian Promoters | % | 0.0 | 64.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 2.2 | 928.8% | |
FIIs | % | 6.2 | 0.2 | 3,670.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 35.3 | 136.4% | |
Shareholders | 56,778 | 30,140 | 188.4% | ||
Pledged promoter(s) holding | % | 0.0 | 19.4 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SMS PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.14% | 0.45% |
1-Month | -1.15% | 12.32% | 2.55% |
1-Year | 0.73% | 147.32% | 56.14% |
3-Year CAGR | -8.76% | 11.19% | 15.22% |
5-Year CAGR | 4.97% | 27.79% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SMS PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SMS PHARMA the stake stands at 64.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SMS PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SMS PHARMA paid Rs 0.3, and its dividend payout ratio stood at 65.4%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SMS PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.